Mahacip 500mg Infusion
Product introduction
Mahacip 500mg Infusion should be used in the dose and duration as advised by your doctor. It may be taken with or without food, preferably at a fixed time. Avoid skipping any doses and finish the full course of treatment even if you feel better. Do not take a double dose to make up for a missed dose. Simply take the next dose as planned.
Common side effects of this medicine include injections site reactions (such as swelling, redness, and pain), nausea, vomiting, and headache. This is usually temporary and resolves on its own, but please consult your doctor if it bothers you or persists for a longer duration. Diarrhea may also occur as a side effect but should stop when your course is complete. Inform your doctor if it does not stop or if you find blood in your stools.
You should not take this medicine if you are allergic to any of its ingredients. Rarely, some people may have a severe allergic reaction which needs urgent medical attention. Signs of this include rash, swelling of the lips, tongue, or face, shortness of breath, or breathing problems. Special care should be taken in people with kidney problems while taking this medicine.
Uses of Mahacip Infusion
Benefits of Mahacip Infusion
In Treatment of Bacterial infections
This medicine usually makes you feel better quite quickly. However, you should continue taking it as long as it is prescribed even when you feel better, to make sure that all bacteria are killed and do not become resistant.
Side effects of Mahacip Infusion
Common side effects of Mahacip
- Injection site reactions (pain, swelling, redness)
- Headache
- Rash
- Dizziness
- Gastrointestinal disorder
How to use Mahacip Infusion
How Mahacip Infusion works
Safety advice
Baby should be closely monitored for development of fever, loss of appetite and diarrhea. In case, any of the above happens please inform your doctor immediately.
Inform your doctor if you develop any signs of jaundice like yellowing of eyes and skin, itching, and clay colored stools while taking this medicine.
What if you forget to take Mahacip Infusion?
All substitutes
Quick tips
- Your doctor has prescribed Mahacip 500mg Infusion to cure your infection and improve symptoms.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Discontinue Mahacip 500mg Infusion and inform your doctor immediately if you get a rash, itchy skin, swelling of face and mouth, or have difficulty in breathing.
- Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it doesn't stop or if you find blood in your stools.
- Notify your doctor if you feel pain in your tendons, numbness, or tingling sensations.
- Inform your doctor if you are pregnant or planning to conceive or breastfeeding.
Fact Box
Patient concerns
FAQs
Is Mahacip 500mg Infusion safe?
Can the use of Mahacip 500mg Infusion cause diarrhea?
Can I stop taking Mahacip 500mg Infusion when I feel better?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Petri WA Jr. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1473-74.
- Chambers HF, Deck DH. Sulfonamides, Trimethoprim, & Quinolons. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 819-20.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 275-78.